📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

JAK-ing up treatment for CRLF2-R ALL. (2022)

First Author: Fielding AK

Attributed to: How do senescent stromal cells subvert the treatment response in acute lymphoblastic leukaemia? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021014196

PubMed Identifier: 35113149

Publication URI: http://europepmc.org/abstract/MED/35113149

Type: Journal Article/Review

Volume: 139

Parent Publication: Blood

Issue: 5

ISSN: 0006-4971